Skip to main content

Table 2 The top-ranked signaling pathways associated with resistance to aromatase inhibitors a

From: MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer

  

Deregulation in Res-Let vs MCF-7aro

Deregulation in Res-Ana vs MCF-7aro

Convergence on the AKT pathway

KEGG pathway

Pathway ID

P -value b

P -value b

Wnt signaling pathway

hsa04310

7.1 × 10−9

7.0 × 10−7

 

TGF-β signaling pathway

hsa04350

2.1 × 10−8

3.0 × 10−4

 

Axon guidance

hsa04360

2.9 × 10−8

7.2 × 10−8

 

Regulation of actin cytoskeleton

hsa04810

1.0 × 10−7

1.5 × 10−5

 

MAPK signaling pathway

hsa04010

1.3 × 10−7

1.8 × 10−4

Yes

Focal adhesion

hsa04510

3.0 × 10−7

8.2 × 10−10

Yes

Adherens junction

hsa04520

2.0 × 10−6

2.4 × 10−6

 

Insulin signaling pathway

hsa04910

1.6 × 10−5

3.5 × 10−10

Yes

Ubiquitin-mediated proteolysis

hsa04120

1.1 × 10−4

4.5 × 10−5

 

ErbB signaling pathway

hsa04012

1.3 × 10−4

4.5 × 10−6

Yes

Tight junction

hsa04530

7.1 × 10−4

NP

Yes

Phosphatidylinositol signaling system

hsa04070

1.3 × 10−3

NP

Yes

mTOR signaling pathway

hsa04150

3.0 × 10−3

2.8 × 10−5

Yes

  1. aMAPK, Mitogen-activated protein kinase; mTOR, Mammalian target of rapamycin; NP, Not present in the top-ranked signaling pathways; TGF-β, Transforming growth factor β. b P-value was obtained using the DIANA-mirPath algorithm to identify significantly deregulated Kyoto Encyclopedia of Genes and Genomes (KEGG) signaling pathways predicted to be altered by the microRNAs selected in our study (Table 1).